
PIT
CAS No. 56583-49-4
PIT ( —— )
产品货号. M33909 CAS No. 56583-49-4
PIT (2,2'-Pyridylisatogen tosylate) 是 P2Y1 受体 的选择性和非竞争性拮抗剂,对人 P2Y1 受体的 IC50 值为 0.14 μM。PIT 在不影响核苷酸结合的情况下拮抗 P2Y1 受体信号。PIT 是一些平滑肌中代谢性嘌呤受体 (P2Y 家族) 对 ATP 反应的不可逆拮抗剂。PIT 可用于慢性支气管炎和哮喘的研究。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥275 | 有现货 |
![]() ![]() |
10MG | ¥468 | 有现货 |
![]() ![]() |
25MG | ¥923 | 有现货 |
![]() ![]() |
50MG | ¥1548 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称PIT
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述PIT (2,2'-Pyridylisatogen tosylate) 是 P2Y1 受体 的选择性和非竞争性拮抗剂,对人 P2Y1 受体的 IC50 值为 0.14 μM。PIT 在不影响核苷酸结合的情况下拮抗 P2Y1 受体信号。PIT 是一些平滑肌中代谢性嘌呤受体 (P2Y 家族) 对 ATP 反应的不可逆拮抗剂。PIT 可用于慢性支气管炎和哮喘的研究。
-
产品描述PIT (2,2'-Pyridylisatogen tosylate) is a selective and non-competitive antagonist of P2Y1 receptor with an IC50 value of 0.14 μM for human P2Y1 receptor. PIT antagonizes P2Y1 receptor signaling without affecting nucleotide binding. PIT is an irreversible antagonist of responses to ATP at metabotropic purinoceptors (of the P2Y family) in some smooth muscles. PIT can be used for the research of chronic bronchitis and asthma.
-
体外实验PIT (0.1-10 μM) non-competitively and dose-dependently diminishs human P2Y1 receptor signaling with an IC50 value of 0.14 μM.PIT (0.1-10 μM) completely blocks the agonist activity of 2-MeSADP.PIT (1 nM-10 μM) dose-dependently inhibits the accumulation of inositol phosphates induced by the agonist 2-MeSADP.PIT (1 nM-10 μM) dose-dependently blocks the P2Y1 receptor signaling induced by the endogenous agonist ADP.PIT (0.1-3 μM) increases ATP-responses 2-5 fold, while higher concentrations (3-100 μM) inhibits ATP-mediated inward current with an IC50 value of 13.2 μM.PIT shows a low affinity for a range of membrane receptors, including: α1, α2-adrenoceptors, 5-HT1A, 5-HT1B, 5-HT2, 5-HT3, D1, D2, muscarinic, central benzodiazepine, H1, μ-opioid, dihydropyridine and batrachotoxin receptors with pKi values of <5.PIT shows affinity to an adenosine (A1) receptor with a pKi value of5.3.PIT (12.5-50 μM) irreversibly antagonizes relaxations of ATP in guinea-pig isolated taenia caeca.
-
体内实验PIT (10 mg/kg; i.p.; for 5 days) significantly protects both the white matter and the cortical plate lesions against the insult in mice with S-bromo-willardiine injection induced tonic and tonicoclonic seizures.
-
同义词——
-
通路GPCR/G Protein
-
靶点P2Y Receptor
-
受体P2Y Receptor
-
研究领域——
-
适应症——
化学信息
-
CAS Number56583-49-4
-
分子量396.42
-
分子式C20H16N2O5S
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO 中的溶解度 : 83.33 mg/mL (210.21 mM; 超声助溶 (<70°C)
-
SMILESCc1ccc(cc1)S(O)(=O)=O.[O-][N+]1=C(C(=O)c2ccccc12)c1ccccn1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Gao ZG, et al. 2,2'-Pyridylisatogen tosylate antagonizes P2Y1 receptor signaling without affecting nucleotide binding. Biochem Pharmacol. 2004 Jul 15;68(2):231-7.?
产品手册




关联产品
-
Clopidogrel
噻吩并吡啶类抗血小板化合物,通过不可逆地抑制血小板上的 P2Y12 受体发挥作用。
-
Ticagrelor
一种有效、选择性、可逆的口服 P2Y12 受体拮抗剂,pKi 为 8.7。
-
YM-254890
YM 254890 是一种选择性 Gq 信号传导抑制剂。